Skip to main content

Table 5 National-level budget impact analysis (in EUR)

From: Budget impact analysis of lens material on the posterior capsule opacification (PCO) as a complication after the cataract surgery

 2-year follow-up
Lens structure (hydrophobic/hydrophilic)0%/100%20%/80%40%/60%60%/40%80%/20%100%/0%
Expected rate of complications22.00%18.58%15.16%11.74%8.32%4.90%
Cataract surgery1,35,746,8441,35,746,8441,35,746,8441,35,746,8441,35,746, 8441,35,746,844
Nd:YAG4,495,6833,796,8083,097,9342,399,0601,700,1851,001,311
Consultation6,42,2405,42,4014,42,5623,42,7232,42,8841,43,044
Diclofenac2,78,8932,35,5381,92,1831,48,8271,05,47262,117
Total1,41,163,6601,40,321,5921,39,479,5231,38,637,4541,37,795,3861,36,953,317
 3-year follow-up
Lens structure (hydrophobic/hydrophilic)0%/100%20%/80%40%/60%60%/40%80%/20%100%/0%
Expected rate of complications30.0%26.80%23.60%20.40%17.20%14.00%
Cataract surgery1,35,746,8441,35,746,8441,35,746,8441,35,746,8441,35,746,8441,35,746,844
Nd:YAG6,130,4765,476,5594,822,6414,168,7243,514,8062,860,889
Consultation8,75,7827,82,3666,88,9495,95,5325,02,1154,08,698
Diclofenac3,80,3083,39,7422,99,1762,58,6102,18,0441,77,477
Total1,43, 133,4111,42,345,5111,41,557,6101,40, 769,7101,39, 981,8091,39,193,909
  1. Source Own calculation